{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:43:59Z","timestamp":1790700239728,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"vor","delay-in-days":45,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Science Research Cultivation Program of Stomatological Hospital, School of Stomatology, Southern Medical University","award":["PY2023015"],"award-info":[{"award-number":["PY2023015"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Head Face Med"],"DOI":"10.1186\/s13005-026-00590-5","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T10:04:52Z","timestamp":1769767492000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Global pharmacovigilance analysis of antimicrobials used in periodontal therapy: safety profiles of minocycline, doxycycline, and chlorhexidine"],"prefix":"10.1186","volume":"22","author":[{"given":"Wanchen","family":"Ning","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linxin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel R.","family":"Reissmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Kreher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Schmalz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxing","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaohong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,30]]},"reference":[{"key":"590_CR1","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/j.1600-0757.1997.tb00104.x","volume":"15","author":"M Addy","year":"1997","unstructured":"Addy M, Moran JM. Clinical indications for the use of chemical adjuncts to plaque control: chlorhexidine formulations. Periodontol 2000. 1997;15:52\u20134. https:\/\/doi.org\/10.1111\/j.1600-0757.1997.tb00104.x.","journal-title":"Periodontol 2000"},{"issue":"11","key":"590_CR2","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1902\/jop.2004.75.11.1553","volume":"75","author":"American Academy of Periodontology","year":"2004","unstructured":"American Academy of Periodontology. Position Paper: Systemic Antibiotics in Periodontics. J Periodontol. 2004;75(11):1553\u201365. https:\/\/doi.org\/10.1902\/jop.2004.75.11.1553.","journal-title":"J Periodontol"},{"key":"590_CR3","doi-asserted-by":"publisher","unstructured":"Bertagnolio S, Dobreva Z, Centner CM, et al. WHO global research priorities for antimicrobial resistance in human health. Lancet Microbe. 2024;5(11):100902. https:\/\/doi.org\/10.1016\/S2666-5247(24)00134-4.","DOI":"10.1016\/S2666-5247(24)00134-4"},{"issue":"Suppl 20","key":"590_CR4","first-page":"S1","volume":"45","author":"JG Caton","year":"2018","unstructured":"Caton JG, Armitage G, Berglundh T, Chapple ILC, Jepsen S, Kornman KS, et al. A new classification scheme for periodontal and peri-implant diseases and conditions - introduction and key changes from the 1999 classification. J Clin Periodontol. 2018;45(Suppl 20):S1\u20138.","journal-title":"J Clin Periodontol"},{"issue":"7","key":"590_CR5","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1902\/jop.2017.170172","volume":"89","author":"L Chambrone","year":"2018","unstructured":"Chambrone L, Wang HL, Romanos GE. Antimicrobial photodynamic therapy for the treatment of periodontitis and peri-implantitis: an American Academy of Periodontology best evidence review. J Periodontol. 2018;89(7):783\u2013803. https:\/\/doi.org\/10.1902\/jop.2017.170172.","journal-title":"J Periodontol"},{"issue":"Suppl 14","key":"590_CR6","doi-asserted-by":"publisher","first-page":"S70","DOI":"10.1111\/jcpe.12062","volume":"40","author":"T Dietrich","year":"2013","unstructured":"Dietrich T, Sharma P, Walter C, Weston P, Beck J. The epidemiological evidence behind the association between periodontitis and incident atherosclerotic cardiovascular disease. J Clin Periodontol. 2013;40(Suppl 14):S70\u201384. https:\/\/doi.org\/10.1111\/jcpe.12062.","journal-title":"J Clin Periodontol"},{"issue":"6","key":"590_CR7","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1002\/pds.677","volume":"10","author":"SJ Evans","year":"2001","unstructured":"Evans SJ, Waller PC, Davis S. Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports. Pharmacoepidemiol Drug Saf. 2001;10(6):483\u20136. https:\/\/doi.org\/10.1002\/pds.677.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"590_CR8","doi-asserted-by":"publisher","unstructured":"Fragkioudakis I, Riggio MP, Apatzidou DA. Understanding the microbial components of periodontal diseases and periodontal treatment-induced microbiological shifts. J Med Microbiol. 2021;70(1). https:\/\/doi.org\/10.1099\/jmm.0.001247.","DOI":"10.1099\/jmm.0.001247"},{"issue":"3","key":"590_CR9","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1111\/bph.12362","volume":"171","author":"F Franconi","year":"2014","unstructured":"Franconi F, Campesi I. Pharmacogenomics, pharmacokinetics and pharmacodynamics: interaction with biological differences between men and women. Br J Pharmacol. 2014;171(3):580\u201394. https:\/\/doi.org\/10.1111\/bph.12362.","journal-title":"Br J Pharmacol"},{"issue":"4","key":"590_CR10","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1902\/jop.2006.050140","volume":"77","author":"G Greenstein","year":"2006","unstructured":"Greenstein G. Local drug delivery in the treatment of periodontal diseases: assessing the clinical significance of the results. J Periodontol. 2006;77(4):565\u201378. https:\/\/doi.org\/10.1902\/jop.2006.050140.","journal-title":"J Periodontol"},{"issue":"6","key":"590_CR11","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/clpt.2013.24","volume":"93","author":"R Harpaz","year":"2013","unstructured":"Harpaz R, DuMouchel W, LePendu P, Bauer-Mehren A, Ryan P, Shah NH. Performance of pharmacovigilance signal-detection algorithms for the FDA adverse event reporting system. Clin Pharmacol Ther. 2013;93(6):539\u201346. https:\/\/doi.org\/10.1038\/clpt.2013.24.","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"590_CR12","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/prd.12121","volume":"71","author":"K Jepsen","year":"2016","unstructured":"Jepsen K, Jepsen S. Antibiotics\/antimicrobials: systemic and local administration in the therapy of mild to moderately advanced periodontitis. Periodontol 2000. 2016;71(1):82\u2013112. https:\/\/doi.org\/10.1111\/prd.12121.","journal-title":"Periodontol 2000"},{"issue":"6","key":"590_CR13","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1111\/jcpe.12726","volume":"44","author":"MT John","year":"2017","unstructured":"John MT, Michalowicz BS, Kotsakis GA, Chu H. Network meta-analysis of studies included in the clinical practice guideline on the nonsurgical treatment of chronic periodontitis. J Clin Periodontol. 2017;44(6):603\u201311. https:\/\/doi.org\/10.1111\/jcpe.12726.","journal-title":"J Clin Periodontol"},{"issue":"14","key":"590_CR14","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.2174\/1381612822666161124154549","volume":"23","author":"I Kanwar","year":"2017","unstructured":"Kanwar I, Sah AK, Suresh PK. Biofilm-mediated antibiotic-resistant oral bacterial infections: mechanism and combat strategies. Curr Pharm Des. 2017;23(14):2084\u201395. https:\/\/doi.org\/10.2174\/1381612822666161124154549.","journal-title":"Curr Pharm Des"},{"issue":"11","key":"590_CR15","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1177\/0022034514552491","volume":"93","author":"NJ Kassebaum","year":"2014","unstructured":"Kassebaum NJ, Bernab\u00e9 E, Dahiya M, Bhandari B, Murray CJ, Marcenes W. Global burden of severe periodontitis in 1990\u20132010: a systematic review and meta-regression. J Dent Res. 2014;93(11):1045\u201353. https:\/\/doi.org\/10.1177\/0022034514552491.","journal-title":"J Dent Res"},{"issue":"3","key":"590_CR16","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/j.0105-1873.2004.00308.x","volume":"50","author":"AB Krautheim","year":"2004","unstructured":"Krautheim AB, Jermann TH, Bircher AJ. Chlorhexidine anaphylaxis: case report and review of the literature. Contact Dermatitis. 2004;50(3):113\u20136. https:\/\/doi.org\/10.1111\/j.0105-1873.2004.00308.x.","journal-title":"Contact Dermatitis"},{"issue":"5","key":"590_CR17","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1177\/009286150804200501","volume":"42","author":"M Lindquist","year":"2008","unstructured":"Lindquist M. Vigibase, the WHO global icsr database system: basic facts. Drug Inf J. 2008;42(5):409\u201319. https:\/\/doi.org\/10.1177\/009286150804200501.","journal-title":"Drug Inf J"},{"issue":"Suppl 18","key":"590_CR18","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1111\/jcpe.12679","volume":"44","author":"PD Marsh","year":"2017","unstructured":"Marsh PD, Zaura E. Dental biofilm: Ecological interactions in health and disease. J Clin Periodontol. 2017;44(Suppl 18):S12\u201322. https:\/\/doi.org\/10.1111\/jcpe.12679.","journal-title":"J Clin Periodontol"},{"issue":"3","key":"590_CR19","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/jcpe.12026","volume":"40","author":"P Matesanz-P\u00e9rez","year":"2013","unstructured":"Matesanz-P\u00e9rez P, Garc\u00eda-Gargallo M, Figuero E, Bascones-Mart\u00ednez A, Sanz M, Herrera D. A systematic review on the effects of local antimicrobials as adjuncts to subgingival debridement, compared with subgingival debridement alone, in the treatment of chronic periodontitis. J Clin Periodontol. 2013;40(3):227\u201341. https:\/\/doi.org\/10.1111\/jcpe.12026.","journal-title":"J Clin Periodontol"},{"issue":"16","key":"590_CR20","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1001\/archinte.167.16.1752","volume":"167","author":"TJ Moore","year":"2007","unstructured":"Moore TJ, Cohen MR, Furberg CD. Serious adverse drug events reported to the Food and Drug Administration, 1998\u20132005. Arch Intern Med. 2007;167(16):1752\u20139. https:\/\/doi.org\/10.1001\/archinte.167.16.1752.","journal-title":"Arch Intern Med"},{"issue":"11","key":"590_CR21","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/sj.bdj.2012.1086","volume":"213","author":"MN Pemberton","year":"2012","unstructured":"Pemberton MN, Gibson J. Chlorhexidine and hypersensitivity reactions in dentistry. Br Dent J. 2012;213(11):547\u201350. https:\/\/doi.org\/10.1038\/sj.bdj.2012.1086.","journal-title":"Br Dent J"},{"issue":"5","key":"590_CR22","doi-asserted-by":"publisher","first-page":"373","DOI":"10.2165\/11599100-000000000-00000","volume":"35","author":"S Piening","year":"2012","unstructured":"Piening S, Haaijer-Ruskamp FM, de Vries JT, van der Elst ME, de Graeff PA, Straus SM, et al. Impact of safety-related regulatory action on clinical practice: a systematic review. Drug Saf. 2012;35(5):373\u201385. https:\/\/doi.org\/10.2165\/11599100-000000000-00000.","journal-title":"Drug Saf"},{"issue":"8","key":"590_CR23","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1002\/pds.1001","volume":"13","author":"KJ Rothman","year":"2004","unstructured":"Rothman KJ, Lanes S, Sacks ST. The reporting odds ratio and its advantages over the proportional reporting ratio. Pharmacoepidemiol Drug Saf. 2004;13(8):519\u201323. https:\/\/doi.org\/10.1002\/pds.1001.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"Suppl 22","key":"590_CR24","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/jcpe.13290","volume":"47","author":"M Sanz","year":"2020","unstructured":"Sanz M, Herrera D, Kebschull M, Chapple I, Jepsen S, Beglundh T, et al. Treatment of stage I-III periodontitis-the EFP S3 level clinical practice guideline. J Clin Periodontol. 2020;47(Suppl 22):4\u201360. https:\/\/doi.org\/10.1111\/jcpe.13290.","journal-title":"J Clin Periodontol"},{"issue":"8","key":"590_CR25","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1002\/JPER.21-0120","volume":"92","author":"FA Scannapieco","year":"2021","unstructured":"Scannapieco FA, Dongari-Bagtzoglou A. Dysbiosis revisited: understanding the role of the oral microbiome in the pathogenesis of gingivitis and periodontitis: a critical assessment. J Periodontol. 2021;92(8):1071\u20138. https:\/\/doi.org\/10.1002\/JPER.21-0120.","journal-title":"J Periodontol"},{"issue":"1","key":"590_CR26","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1902\/annals.2003.8.1.70","volume":"8","author":"FA Scannapieco","year":"2003","unstructured":"Scannapieco FA, Bush RB, Paju S. Periodontal disease as a risk factor for adverse pregnancy outcomes. A systematic review. Ann Periodontol. 2003;8(1):70\u20138. https:\/\/doi.org\/10.1902\/annals.2003.8.1.70.","journal-title":"Ann Periodontol"},{"key":"590_CR27","doi-asserted-by":"publisher","unstructured":"Slots, J\u00f8rgen, Research, Science and Therapy Committee. \u201cSystemic antibiotics in periodontics.\u201d J periodontol. 2004;75(11):1553-65.\u00a0https:\/\/doi.org\/10.1902\/jop.2004.75.11.1553.","DOI":"10.1902\/jop.2004.75.11.1553"},{"issue":"7","key":"590_CR28","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.adaj.2015.01.026","volume":"146","author":"CJ Smiley","year":"2015","unstructured":"Smiley CJ, Tracy SL, Abt E, Michalowicz BS, John MT, Gunsolley J, et al. Evidence-based clinical practice guideline on the nonsurgical treatment of chronic periodontitis by means of scaling and root planing with or without adjuncts. J Am Dent Assoc. 2015;146(7):525\u201335. https:\/\/doi.org\/10.1016\/j.adaj.2015.01.026.","journal-title":"J Am Dent Assoc"},{"key":"590_CR29","doi-asserted-by":"publisher","unstructured":"Song H, Pei X, Liu Z, Shen C, Sun J, Liu Y, et al. Pharmacovigilance in China: Evolution and future challenges. British J Clin Pharmacol.\u00a02023;89(2):510\u201322.https:\/\/doi.org\/10.1111\/bcp.15277.","DOI":"10.1111\/bcp.15277"},{"issue":"Suppl 22","key":"590_CR30","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/jcpe.13245","volume":"47","author":"J Suvan","year":"2020","unstructured":"Suvan J, Leira Y, Moreno Sancho FM, Graziani F, Derks J, Tomasi C. Subgingival instrumentation for treatment of periodontitis. A systematic review. J Clin Periodontol. 2020;47(Suppl 22):155\u201375. https:\/\/doi.org\/10.1111\/jcpe.13245.","journal-title":"J Clin Periodontol"},{"issue":"10","key":"590_CR31","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.3390\/antibiotics10101178","volume":"10","author":"OL Tan","year":"2021","unstructured":"Tan OL, Safii SH, Razali M. Clinical efficacy of repeated applications of local drug delivery and adjunctive agents in nonsurgical periodontal therapy: a systematic review. Antibiotics. 2021;10(10):1178. https:\/\/doi.org\/10.3390\/antibiotics10101178.","journal-title":"Antibiotics"},{"issue":"Suppl 1","key":"590_CR32","doi-asserted-by":"publisher","first-page":"S159","DOI":"10.1002\/JPER.18-0006","volume":"89","author":"MS Tonetti","year":"2018","unstructured":"Tonetti MS, Greenwell H, Kornman KS. Staging and grading of periodontitis: framework and proposal of a new classification and case definition. J Periodontol. 2018;89(Suppl 1):S159\u201372. https:\/\/doi.org\/10.1002\/JPER.18-0006.","journal-title":"J Periodontol"},{"issue":"5","key":"590_CR33","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1111\/jcpe.12732","volume":"44","author":"MS Tonetti","year":"2017","unstructured":"Tonetti MS, Jepsen S, Jin L, Otomo-Corgel J. Impact of the global burden of periodontal diseases on health, nutrition and wellbeing of mankind: a call for global action. J Clin Periodontol. 2017;44(5):456\u201362. https:\/\/doi.org\/10.1111\/jcpe.12732.","journal-title":"J Clin Periodontol"},{"issue":"Suppl 14","key":"590_CR34","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.1111\/jcpe.12089","volume":"40","author":"MS Tonetti","year":"2013","unstructured":"Tonetti MS, Van Dyke TE, Working group 1 of the joint EFP\/AAP workshop. Periodontitis and atherosclerotic cardiovascular disease: consensus report of the Joint EFP\/AAP Workshop on Periodontitis and Systemic Diseases. J Clin Periodontol. 2013;40(Suppl 14):S24\u20139. https:\/\/doi.org\/10.1111\/jcpe.12089.","journal-title":"J Clin Periodontol"},{"issue":"1","key":"590_CR35","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/pds.668","volume":"11","author":"EP van Puijenbroek","year":"2002","unstructured":"van Puijenbroek EP, Bate A, Leufkens HG, Lindquist M, Orre R, Egberts AC. A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions. Pharmacoepidemiol Drug Saf. 2002;11(1):3\u201310. https:\/\/doi.org\/10.1002\/pds.668.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"8","key":"590_CR36","doi-asserted-by":"publisher","first-page":"573","DOI":"10.7326\/0003-4819-147-8-200710160-00010","volume":"147","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med. 2007;147(8):573\u20137. https:\/\/doi.org\/10.7326\/0003-4819-147-8-200710160-00010.","journal-title":"Ann Intern Med"},{"key":"590_CR37","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-24277-4","volume-title":"ggplot2: Elegant graphics for data analysis","author":"H Wickham","year":"2016","unstructured":"Wickham H. ggplot2: Elegant graphics for data analysis. New York: Springer-Verlag; 2016. https:\/\/doi.org\/10.1007\/978-3-319-24277-4."},{"key":"590_CR38","unstructured":"World Health Organization (WHO)-Uppsala Monitoring Centre. The use of the WHO-UMC system for standardized case causality assessment. Available from:\u00a0https:\/\/www.who.int\/docs\/default-source\/medicines\/pharmacovigilance\/whocausality-assessment.pdf. Accessed on 2024 Nov."},{"key":"590_CR39","doi-asserted-by":"publisher","first-page":"1479152","DOI":"10.3389\/fphys.2024.1479152","volume":"15","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, Zhang Z, Zhang G. Systemic doxycycline as an adjunct to nonsurgical periodontal therapy in diabetic patients with periodontitis: a systematic review and meta-analysis. Front Physiol. 2025;15:1479152. https:\/\/doi.org\/10.3389\/fphys.2024.1479152.","journal-title":"Front Physiol"},{"key":"590_CR40","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.yfrne.2015.07.00","volume":"40","author":"Y Zhou","year":"2016","unstructured":"Zhou Y, Zhao M, Zhou C, Li R. Sex differences in drug addiction and response to exercise intervention: from human to animal studies. Front Neuroendocrinol. 2016;40:24\u201341. https:\/\/doi.org\/10.1016\/j.yfrne.2015.07.00.","journal-title":"Front Neuroendocrinol"}],"container-title":["Head & Face Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13005-026-00590-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13005-026-00590-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13005-026-00590-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T10:53:00Z","timestamp":1773658380000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13005-026-00590-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["590"],"URL":"https:\/\/doi.org\/10.1186\/s13005-026-00590-5","relation":{},"ISSN":["1746-160X"],"issn-type":[{"value":"1746-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,30]]},"assertion":[{"value":"11 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study analyzed publicly available, de-identified data from the WHO VigiAccess database. No institutional ethics approval was required as per international guidelines for pharmacovigilance research using anonymized aggregate data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26"}}